Effect of Music on Cue Reactivity for Patients With Opioid Use Disorder
NCT ID: NCT06948890
Last Updated: 2025-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
28 participants
INTERVENTIONAL
2025-04-20
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Music on Pain and Anxiety After Surgery
NCT01409044
Effect and Safety of Listening to Music for Chronic Pain Relief
NCT05726266
Sleep & Stress in Healthcare Providers After Defined Music Intervention Measure by 7-Tesla fMRI & Actigraphy
NCT05980429
The Impact of Music on Nociceptive Processing
NCT04087564
Jazz Music and Mindfulness for Chronic Pain
NCT05979012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Music, with its profound emotional and psychological effects, may offer a unique avenue for intervention. Previous research has demonstrated that music can influence mood, reduce anxiety, and enhance emotional regulation. Listening to music may also attenuate nociceptive processing and change thresholds of pain tolerance. By examining how specific musical stimuli interact with drug-related cues, the researchers hope to identify whether music can serve as an adjunctive strategy or an emotional anchor that diminishes cravings associated with opioid cues. This research seeks to contribute to the development of innovative therapeutic strategies aimed at reducing relapse rates and promoting recovery among individuals struggling with OUD.
Through a carefully designed mixed methods experimental framework, the researchers will assess the effects of different musical genres on cue-induced cravings. It is anticipated that the findings will provide valuable insights into the potential of music as a complementary tool in the treatment of opioid use disorder, paving the way for more holistic and effective recovery approaches.
Specific Aim 1: To determine the effect of music on cue-induced craving for individuals with opioid use disorder compared to a control condition (silence).
Hypothesis 1: Compared to the control condition, listening to music will attenuate cue-induced craving as assessed on a 100-point VAS craving scale.
Specific Aim 2: Identify the role of music in people's use of opioids through individual interviews with study participants.
Hypothesis 2: There will be key themes that emerge related to people's use of opioids as well as in their treatment and recovery.
This is a donor-funded, open label, pilot, proof-of-concept study with two parts. The study will aim to randomize N=28 individuals (14 in control arm and 14 in intervention arm) who have a history of opioid use disorder. Individuals will be recruited from a variety of means including online study recruitment and through fliers stationed at MGB-affiliated addiction clinics (including the Brigham and Women's Hospital and Massachusetts General Hospital Bridge Clinics, the Faulkner Addiction Recovery Program, and the MGH West End clinic).
Participants who agree to participate in the study will come to the Center for Clinical Investigation (CCI) once. The entirety of the study for each participant entails one CCI visit.
In the first phase, participants will answer a demographic questionnaire and a variety of psychological assessments. They will answer a question pertaining to their degree of opioid craving at that moment, on a 100-point visual analog scale (VAS). They will then be randomized to listen to music (2 songs chosen by them, maximum 10 minutes) or 10 minutes of noise cancelation. Participants will then be shown a series of images related to opioid use. They will complete the craving scale again. They will be shown a series of neutral images that do not pertain to drug use, and the craving scale will be administered again. Finally, they will complete the Absorption in Music Scale.
The second phase, for all participants regardless of randomization in the first phase, will be a qualitative interview asking subjects about their relationship with music, and how music pertained to their past drug use and/or recovery. Researchers will also ask participants about their experience participating in the trial and potential strategies to expand music use and recommendations in clinical settings for OUD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
music
In this arm, subjects will rate their cravings for opioids on a 0-100 point visual analog scale. They will then listen to 2 songs of their choosing. They will then be shown a series of images "cues" related to drug use, and will again be asked their cravings for opioids.
Music intervention
Subjects will listen to two songs of their choosing. They will be prompted: "Please choose two songs that you really enjoy and that make you feel relaxed or take away stress".
silence
In this arm, subjects will rate their cravings for opioids on a 0-100 point visual analog scale. They will then listen to 10 minutes of silence. They will then be shown a series of images "cues" related to drug use, and will again be asked their cravings for opioids.
Silence
Subjects will listen to 10 minutes of silence through high quality noise canceling headphones
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Music intervention
Subjects will listen to two songs of their choosing. They will be prompted: "Please choose two songs that you really enjoy and that make you feel relaxed or take away stress".
Silence
Subjects will listen to 10 minutes of silence through high quality noise canceling headphones
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current diagnosis of opioid use disorder
* Actively receiving buprenorphine or methadone treatment with a stable dose of at least 30 days
Exclusion Criteria
* Hearing impaired
* Vision impaired
* Patient reports that they are pregnant
* Requiring the use of any prescription opioid analgesics during the trial
* Currently prescribed naltrexone
* Chronic pain, defined as pain on the numeric rating scale (0-10) of \>3 every day for over 3 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scott G. Weiner, MD, MPH
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott G Weiner, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Suzuki J, Martin B, Prostko S, Chai PR, Weiss RD. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study. Integr Med Rep. 2022 Aug 1;1(1):157-163. doi: 10.1089/imr.2022.0070. Epub 2022 Aug 26.
Chai PR, Carreiro S, Ranney ML, Karanam K, Ahtisaari M, Edwards R, Schreiber KL, Ben-Ghaly L, Erickson TB, Boyer EW. Music as an Adjunct to Opioid-Based Analgesia. J Med Toxicol. 2017 Sep;13(3):249-254. doi: 10.1007/s13181-017-0621-9. Epub 2017 Jun 23.
Chai PR, Schreiber KL, Taylor SW, Jambaulikar GD, Kikut A, Hasdianda MA, Boyer EW. The Feasibility and Acceptability of a Smartphone-Based Music Intervention for Acute Pain. Proc Annu Hawaii Int Conf Syst Sci. 2019 Jan 8;2019:3917-3925.
Chai PR, Schwartz E, Hasdianda MA, Azizoddin DR, Kikut A, Jambaulikar GD, Edwards RR, Boyer EW, Schreiber KL. A Brief Music App to Address Pain in the Emergency Department: Prospective Study. J Med Internet Res. 2020 May 20;22(5):e18537. doi: 10.2196/18537.
Colebaugh CA, Wilson JM, Flowers KM, Overstreet D, Wang D, Edwards RR, Chai PR, Schreiber KL. The Impact of Varied Music Applications on Pain Perception and Situational Pain Catastrophizing. J Pain. 2023 Jul;24(7):1181-1192. doi: 10.1016/j.jpain.2023.01.006. Epub 2023 Jan 14.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025P000151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.